Hematology NewsFDA expands approval of brentuximab vedotin to PTCLNovember 16, 2018T Cell LymphomasLymphoma & Plasma Cell DisordersAggressive Lymphomas
Hematology TimesQuick FDA approval for brentuximab vedotin in PTCLNovember 16, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesR-CHOP effective as first-line treatment in FLNovember 16, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
Hematology NewsR-CHOP looks viable as first line in follicular lymphomaNovember 15, 2018Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular LymphomaB Cell Lymphoma
Hematology NewsBortezomib may unlock resistance in WM with mutationsNovember 15, 2018Indolent LymphomaLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsRelapsed MCL: Options for treatmentNovember 15, 2018Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsCLL: The initial work-upNovember 13, 2018CLLIndolent LymphomaLymphoma & Plasma Cell DisordersB Cell Lymphoma
The Journal of Community and Supportive OncologyA ‘double-hit’ bone marrow rare co-occurrence of 2 different pathologiesNovember 13, 2018Lymphoma & Plasma Cell Disorders
Hematology TimesFinancial burden of blood cancers in the U.S.November 12, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaMyelodysplastic Syndrome
Hematology NewsP-BCMA-101 gains FDA regenerative medicine designationNovember 9, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsAberrant RNA editing linked to aggressive myelomaNovember 8, 2018Multiple MyelomaLymphoma & Plasma Cell DisordersTranslational Research
Hematology NewsFDA puts selinexor on fast track for DLBCLNovember 8, 2018Aggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsReport details financial burden of blood cancersNovember 8, 2018Business of MedicinePractice ManagementLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLMultiple Myeloma
Hematology TimesFDA clears portable hematology analyzerNovember 8, 2018CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
Hematology TimesSelinexor on fast track for DLBCLNovember 8, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
